Jefferies Group's CRL Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 18,270 shares of Charles River Laboratories International, Inc. (CRL) worth $4.14 M, representing 0.03% of the portfolio. First purchased in 2023-Q3, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in CRL, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 18,270 shares. Largest reduction occurred in Q2 2024, reducing 8,720 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +18,270 | New Buy | 18,270 | $226.79 |
| Q4 2025 | -5,000 | Sold Out | 0 | $0.00 |
| Q3 2025 | -3,872 | Reduce 43.64% | 5,000 | $156.46 |
| Q2 2025 | -4,742 | Reduce 34.83% | 8,872 | $151.73 |
| Q1 2025 | -4,188 | Reduce 23.53% | 13,614 | $150.52 |
| Q4 2024 | +12,353 | Add 226.70% | 17,802 | $184.60 |
| Q3 2024 | +5,449 | New Buy | 5,449 | $196.97 |
| Q2 2024 | -8,720 | Sold Out | 0 | $0.00 |
| Q1 2024 | +8,720 | New Buy | 8,720 | $270.95 |
| Q4 2023 | -1,199 | Sold Out | 0 | $0.00 |
| Q3 2023 | +1,199 | New Buy | 1,199 | $195.98 |
Jefferies Group's Charles River Laboratories International Investment FAQs
Jefferies Group first purchased Charles River Laboratories International, Inc. (CRL) in Q3 2023, acquiring 1,199 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Charles River Laboratories International, Inc. (CRL) for 11 quarters since Q3 2023.
Jefferies Group's largest addition to Charles River Laboratories International, Inc. (CRL) was in Q2 2026, adding 18,270 shares worth $4.14 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 18,270 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $4.14 M.
As of the Q2 2026 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.03% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Charles River Laboratories International, Inc. (CRL) was 18,270 shares, as reported at the end of Q2 2026.